-7 or del(7q)	chr7	1	159345973	NA	Defining cytogenetic abnormalities in acute myeloid leukaemia, myelodysplasia-related.; Cytogenetic and molecular abnormalities defining acute myeloid leukaemia, myelodysplasia-related., (WHO, PMID: 35732831).	NA	NA	NA	No	No	No	-7 or del(7q)	Structural aberration	AML	1A	NA	Optical Genome Mapping detected a deletion 7q or monosomy 7 in [%] of the sample.	In the context of a diagnosis of AML, deletion 7q is associated with an intermediate prognosis, monosomy 7 is associated with an adverse prognosis (PMID:35797463)
del(5q) or -5	chr5	1	181538259	NA	Classification and defining features of myelodysplastic neoplasms (MDS).; MDS with low blasts and isolated 5q deletion (MDS-5q). Premalignant clonal cytopenias and myelodysplastic syndromes; Myelodysplastic syndrome with del(5q) (WHO, PMID: 35732831).	NA	NA	NA	No	No	No	del(5q) or -5	Structural aberration	AML	1A	NA	Optical Genome Mapping detected a deletion 5q or monosomy 5 in [%] of the sample.	In the context of a diagnosis of AML, this is associated with an adverse prognosis (PMID:35797463)
Complex KT	Complex KT	NA	NA	NA	NA	NA	NA	NA	No	No	No	Complex KT	Structural aberration	AML	1A	NA	Optical Genome Mapping detected a [Complex KT] mutation involving the Complex KT gene on Complex KT with a variant allele frequency (VAF) of [%].	In the context of AML the presence of a complex genome (i.e. karyotype) in associated with an adverse prognosis (PMID: 35797463).
del(17p)	chr17	1	25100000	NA	Defining cytogenetic abnormalities in acute myeloid leukaemia, myelodysplasia-related.; Cytogenetic and molecular abnormalities defining acute myeloid leukaemia, myelodysplasia-related., (WHO, PMID: 35732831).	NA	NA	NA	No	No	No	del(17p)	Structural aberration	AML	1A	NA	Optical Genome Mapping detected a deletion 17p overlapping the region with the TP53 gene, in [%] of the sample.	In the context of AML, Deletion of TP53 is often seen in complex karyotypes and is associatd with a poor prognosis (PMID: 35797463).
idic(X)(q13)	chrX	68500000	76800000	NA	Defining cytogenetic abnormalities in acute myeloid leukaemia, myelodysplasia-related.; Cytogenetic and molecular abnormalities defining acute myeloid leukaemia, myelodysplasia-related., (WHO, PMID: 35732831).	NA	NA	NA	No	No	No	idic(X)(q13)	Structural aberration	AML	1A	NA	Optical Genome Mapping detected a isodicentric chromosome Xq in [%] of the sample.	In the context of AML, idic(Xq) is recurrent abnormality in the context of myeloid neoplasia and in the context of a diagnosis of AML and is associated with an intermediate prognosis (PMID: 35797463)
monosomy 17	chr17	1	83257441	NA	NA	NA	NA	NA	No	No	No	monosomy 17	Structural aberration	AML	1A	NA	Optical Genome Mapping detected a monosomy 17 in [%] of the sample.	In the context of AML, Monosomy of chromosome 17 is often seen in complex karyotypes and is associatd with a  poor prognosis (PMID: 35797463).
Iso(17q)	chr17	25100000	83257441	NA	Defining cytogenetic abnormalities in acute myeloid leukaemia, myelodysplasia-related.; Cytogenetic and molecular abnormalities defining acute myeloid leukaemia, myelodysplasia-related., (WHO, PMID: 35732831).	NA	NA	NA	No	No	No	Iso(17q)	Structural aberration	AML	1A	NA	Optical Genome Mapping detected a loss of chromosome material on chromosome 17p with a concomitant copy number gain on chromosome 17q.	In the context of AML, this pattern is consisent with an isochromosome 17q with in [%] of the sample.
-13 or del(13q)	chr13	0	114364328	NA	Defining cytogenetic abnormalities in acute myeloid leukaemia, myelodysplasia-related.; Cytogenetic and molecular abnormalities defining acute myeloid leukaemia, myelodysplasia-related., (WHO, PMID: 35732831).	NA	NA	NA	No	No	No	-13 or del(13q)	Structural aberration	AML	1A	NA	Optical Genome Mapping detected a [-13 or del(13q)] with a variant allele frequency (VAF) of [%].	NA
del(11q)	chr11	53400000	135086622	NA	Defining cytogenetic abnormalities in acute myeloid leukaemia, myelodysplasia-related.; Cytogenetic and molecular abnormalities defining acute myeloid leukaemia, myelodysplasia-related., (WHO, PMID: 35732831).	NA	NA	NA	No	No	No	del(11q)	Structural aberration	AML	1A	NA	Optical Genome Mapping detected a [del(11q)] with a variant allele frequency (VAF) of [%].	NA
del(12p)	chr12	0	35500000	NA	Defining cytogenetic abnormalities in acute myeloid leukaemia, myelodysplasia-related.; Cytogenetic and molecular abnormalities defining acute myeloid leukaemia, myelodysplasia-related., (WHO, PMID: 35732831).	NA	NA	NA	No	No	No	del(12p)	Structural aberration	AML	1A	NA	Optical Genome Mapping detected a deletion 12p overlapping the region with the ETV6 gene, in [%] of the sample.	NA
Deletion 20q	chr20	28100000	30400000	NA	NA	NA	NA	NA	No	No	No	Deletion 20q	Structural aberration	AML	1A	NA	Optical Genome Mapping detected a [Deletion 20q] with a variant allele frequency (VAF) of [%].	NA
inv(16)(p13.1q22)	chr16	10400000	74100000	NA	NA	Classification of AML with percentage of blasts required for diagnosis; AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11 = 10% (ICC, PMID: 35767897).	NA	NA	No	No	No	inv(16)(p13.1q22)	Structural aberration	AML	1A	NA	Optical Genome Mapping detected a [inv(16)(p13.1q22)] with a variant allele frequency (VAF) of [%].	NA
inv(3)(q21.3q26.2)	chr3	126000000	171200000	NA	NA	Classification of AML with percentage of blasts required for diagnosis; AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/GATA2; MECOM(EVI1) = 10% (ICC, PMID: 35767897).	NA	NA	No	No	No	inv(3)(q21.3q26.2)	Structural aberration	AML	1A	NA	Optical Genome Mapping detected a [inv(3)(q21.3q26.2)] with a variant allele frequency (VAF) of [%].	NA
trisomy 8	chr8	1	145138636	NA	NA	NA	NA	NA	No	No	No	trisomy 8	Structural aberration	AML	1A	NA	Optical Genome Mapping detected a trisomy 8 with a fractional copy number of  [].	NA
